Literature DB >> 33586655

Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.

Takayoshi Komatsu-Fujii1, Marie Ogawa1, Shoko Nonoyama1, Takaya Fukumoto1, Hiroshi Tanabe1.   

Abstract

Entities:  

Year:  2021        PMID: 33586655     DOI: 10.1684/ejd.2020.3957

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  1 in total

Review 1.  High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer.

Authors:  Alyce M Kuo; Alina Markova
Journal:  Front Med (Lausanne)       Date:  2022-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.